Buchan was engaged to develop an investor relations and communications strategy for US company Osprey Medical to support its Initial Public Offer (IPO) and listing on the ASX, which was achieved on 2 May 2012. It was one of few successful IPOs in 2012 due to prevailing investor instability globally.

Buchan’s role was to work closely with the investment banker to raise Osprey Medical’s profile with high net worth, institutional and retail investors through a targeted investor engagement, communication and media program to drive over subscription to the offer, and to support on-market buying post listing.

In order to strongly engage with Australian investors, Buchan centred Osprey Medical’s story around its origins as an Australian R&D project, which was supported by venture capital investors in Australia (CM Capital and Brandon Capital).

Highlights

  • A$20 million raised and Osprey Medical listed on the ASX. The IPO was oversubscribed
  • Only healthcare company to successfully list on the ASX/globally in 2012
  • Osprey Medical nearly doubled its listing value within twelve months of the IPO
  • More than 88 print/broadcast hits, syndicated widely, including the AFR, BRW, The Australian, Herald Sun, The Age, SMH, Sky Business and AAP

"As an ASX listed public company with headquarters in the US, Buchan Consulting helps us improve communication with stakeholders in Australia and analyse information comprehensively to facilitate sound decisions and corporate strategy."

Mike McCormick, President & CEO